A novel animal blood anticoagulant and its application

Abstract

A novel animal blood anticoagulant consisting of long-chain inorganic phosphates and organic phosphates. Wherein: the weight proportion of the long-chain inorganic phosphate and the organic phosphate is: the long-chain inorganic phosphate is 25-75 parts, and the organic phosphate is 25-75 parts. The method of using the above-mentioned novel animal blood anticoagulant is: dissolve the anticoagulant and water in a ratio of 1:10 (w / w) during use, and evenly sprinkle the anticoagulant solution in the blood tank before slaughtering, and then slaughter After the start, the anticoagulant solution is evenly sprayed on the surface of the original blood during the slaughtering process of the livestock and poultry, and the addition ratio of the anticoagulant solution to the original blood is 1:15-1:20 (v / v). Compared with traditional anticoagulants, the anticoagulant has stronger anticoagulant effect, can effectively inhibit hemolysis, reduces the amount of anticoagulant used, and significantly improves the anticoagulant effect of animal blood, which is beneficial to related Enterprise mass production.

Description

Technical field: [0001] The invention discloses a novel animal blood anticoagulant, which is suitable for anticoagulation of raw materials for large-scale production of animal blood products. Background technique: [0002] my country is rich in pig blood resources. Pig blood is rich in various nutrients, among which the protein content is as high as 18.9%, and it also contains trace elements, vitamins, hormones, enzymes and many other active substances, and the content of organic iron is also high. Pig blood is a rich source of animal protein nutrition. Using biological and chemical methods to process pig blood protein into protein feed that is easy for animals to digest and absorb has always been an important research direction in the feed industry. [0003] Because blood clots quickly outside the body, anticoagulants play an important role in the storage and transportation of blood. In modern industrial production, due to the expansion of production scale and the longer t...

AI Technical Summary

Problems solved by technology

In modern industrial production, due to the expansion of production scale and the longer transportation and storage time, the existing anticoagulants can no longer meet the demand, and the domestic related research is relatively lagging behind. The main research direction is human blood anticoagulants, and the use cost is high. However, the development of commercial animal blood anticoagulants for large-scale production is still blank

[0004] The current animal blood anticoagulants generally adopt single-component sodium citrate anticoagulant or ACD anticoagulant for human blood. Among them, the anticoagulant effect of sodium citrate anticoagulant is not good, and ACD anticoagulant is mostly used For human blood, its storage conditions and purpose are quite different from those of animal blood, and it is not suitable for large-scale commercial promotion.